Amgen And LabCentral Announce 2015 Golden Ticket Winners Read more about Amgen And LabCentral Announce 2015 Golden Ticket Winners
New Data Show Consistent Safety Profile For Up To 10 Years With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis Read more about New Data Show Consistent Safety Profile For Up To 10 Years With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis
New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide Read more about New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide
New Data Show Greater Bone Mineral Density Gains With Prolia® (Denosumab) Compared With Zoledronic Acid Read more about New Data Show Greater Bone Mineral Density Gains With Prolia® (Denosumab) Compared With Zoledronic Acid
Amgen Announces Repatha™ Co-Preferred Position on Express Scripts National Formulary Read more about Amgen Announces Repatha™ Co-Preferred Position on Express Scripts National Formulary
Amgen To Give 23 Presentations On Osteoporosis Disease And Treatment At American Society For Bone And Mineral Research Annual Meeting Read more about Amgen To Give 23 Presentations On Osteoporosis Disease And Treatment At American Society For Bone And Mineral Research Annual Meeting
Amgen To Present At The Barclays Biosimilars Symposium Read more about Amgen To Present At The Barclays Biosimilars Symposium
Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™ Initiative To Improve Diagnosis And Care For People With Familial Hypercholesterolemia Read more about Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™ Initiative To Improve Diagnosis And Care For People With Familial Hypercholesterolemia
Amgen Receives CHMP Positive Opinions For Two New Treatment Options For Patients With Blood Cancer In Europe Read more about Amgen Receives CHMP Positive Opinions For Two New Treatment Options For Patients With Blood Cancer In Europe
Amgen To Present New Kyprolis® (carfilzomib) Data At 15th International Myeloma Workshop Read more about Amgen To Present New Kyprolis® (carfilzomib) Data At 15th International Myeloma Workshop
